FDA Updates Bowel Drug Zelnorm Risk Information

Requiring a warning of, "Serious consequences of diarrhea," the Food and Drug Administration (FDA) has announced the addition of new risk information to the health professional labeling for Zelnorm (tegaserod maleate). Zelnorm is a prescription-only medication for the short-term treatment of women with irritable bowel syndrome (IBS). Read more...